Robert Rutstein
Podiatrist · Hartford, CTNPI 1891774915
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $890 and has fallen 83.1% since, to $150 in 2025.
Across 38 payments — averaging $81.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$666
- Integra Lifesciences Corporation$301
- Smith+Nephew$225
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$170
- Solventum Corporation$150
- Osiris Therapeutics Inc.$145
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,102100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 8 | $666 |
| Integra Lifesciences Corporation | 3 | $301 |
| Smith+Nephew | 4 | $225 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $170 |
| Solventum Corporation | 1 | $150 |
| Osiris Therapeutics Inc. | 2 | $145 |
| Gotham Surgical Solutions & Devices, Inc. | 1 | $144 |
| Organogenesis Inc. | 2 | $141 |
| Zimvie Inc. | 2 | $136 |
| Treace Medical Concepts, Inc. | 1 | $135 |
| Johnson & Johnson | 1 | $130 |
| Kerecis Limited | 1 | $121 |
| Triad Life Sciences Inc. | 1 | $119 |
| Next Science LLC | 1 | $118 |
| Axogen | 1 | $112 |
| AbbVie | 1 | $100 |
| KCI USA, Inc. | 1 | $91 |
| Averitas Pharma Inc. | 2 | $54 |
| Sebela Pharmaceuticals Inc. | 1 | $23 |
| Baxter Healthcare | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$799
- INTEGRA DERMAL REGENERATION TEMPLATE$266
- PRIMATRIX$266
- AUGMENT INJECTABLE$262
- MOTOBAND$259
- Stravix$235
- Grafix$235
- PREVENA RESTOR AXIOFORM$150
- V.A.C. VERAFLO CLEANSE CHOICE$150
- HOFFMANN$146
- Lapiplasty System$135
- MOTOBAND CP$130
- MINIBUNION$130
- BRYHALI$125
- GrafixPL$122
- Kerecis Omega3 Wound$121
- Kerecis Omega3 Surgibind$121
- Kerecis Omega3 GraftGuide$121
- Kerecis Omega3 SurgiClose$121
- InnovaMatrix AC$119
How this compares
$3,102 in reported general payments places this provider in the 80th percentile of 119 podiatrist providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 18 | $26,359 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 36 | $1,087 |
| Ammonium Lactate | 47 | $648 |
| Cephalexin | 16 | $66 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $170 | $26,35918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 119 podiatrist providers in Connecticut.
Other podiatrist in Hartford
- Eric KosofskyHartford$5K
- Ashley ShepardHartford$1K
- Peter BlumeNew Haven$481K
- Robert DavisBridgeport$427K
- David NovickiMilford$67K
- Shane ReynoldsNorwalk$14K
- Eric LevineNorwich$12K
- Paul BetschartDanbury$10K
- Michael FeinBethel$9K
- Tehreem SajjadNew Britain$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.